Efficacy and Safety of Cholinesterase Inhibitors for Mild Cognitive Impairment:A Systematic Review and Meta-Analysis

Author:

Matsunaga Shinji1,Fujishiro Hiroshige2,Takechi Hajime1

Affiliation:

1. Department of Geriatrics and Cognitive Disorders, Fujita Health University School of Medicine, Kutsukake, Toyoake, Aichi, Japan

2. Department of Psychiatry, Kawasaki Memorial Hospital, Miyamae, Kawasaki, Kanagawa, Japan

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference40 articles.

1. Mild cognitive impairment;Lopez;Continuum (Minneap Minn),2013

2. The incidence of mild cognitive impairment: A systematic review and data synthesis;Gillis;Alzheimers Dement (Amst),2019

3. Monotherapy is good enough for patients with mild-to-moderate Alzheimer’s disease: A network meta-analysis of 76 randomized controlled trials;Tsoi;Clin Pharmacol Ther,2019

4. Comparative efficacy and safety of cognitive enhancers for treating vascular cognitive impairment: Systematic review and Bayesian network meta-analysis;Jin;Neural Regen Res,2019

5. Matsunaga S , Kishi T , Yasue I , Iwata N (2015) Cholinesterase inhibitors for Lewy body disorders: A meta-analysis. Int J Neuropsychopharmacol 19, pyv086.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3